Implementation of hypofractionated prostate radiotherapy in the United States: A National Cancer Database analysis: Beyond the Abstract

External-beam radiotherapy has an established role as a non-invasive treatment for prostate cancer. Traditionally, this treatment has consisted of conventional fractionation, which entails roughly 8-9 weeks of treatment delivered 5 days per week. While many patients tolerate this regimen quite well, it can impose significant logistical burdens on patients and families.